RESEARCH & DEVELOPMENT

Icagen has developed a broad pipeline targeting specific ion channels for the treatment of a wide range of diseases. Spanning multiple therapeutic areas, our pipeline demonstrates our ability to harness our core ion channel technology for the discovery and development of novel therapeutics.  The Company is conducting research and development activities, in some cases in collaboration with major pharmaceutical companies, in a number of disease areas, including epilepsy; asthma; pain and inflammation.